CD40 and neoplasm: Using the KPC model of intraepithelial pancreatic tumorigenesis, cDC1 dysfunction and apoptosis was shown to be neutralized in vivo by IL-6 blockade, and CD40-agonist restored cDC1 maturation and abundance, resulting in enhanced control of tumor outgrowth [183].